Hints and tips:
Related Special Reports
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...China has urged Japan to retract new restrictions on exports of semiconductor manufacturing equipment announced last month....
...When acquired, in fairness, Vectura was reshaping its business to become a contract development and manufacturing organisation, using its expertise on behalf of other pharma companies....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...Entente cordiale with the Chinese Communist party affords Apple a charmed existence when it comes to manufacturing and selling products in China. But scary data points keep popping up....
...Officials said the commission and EU governments had agreed to pay a higher price to secure proved supplies from European manufacturing plants....
...They require some of the same ingredients and manufacturing capacity as the Covid-19 vaccine that Pfizer has co-developed with Germany’s BioNTech....
...The contract had included public investment into manufacturing facilities in Scotland....
...Pfizer could revisit its bullish manufacturing plans to tackle any supply glut, he added....
...Toshifumi Tada, head of vaccine business development at Mitsubishi Tanabe Pharma, said its subsidiary Medicago would apply for Canadian approval for its vaccine candidate that is made from a plant from the...
...A push by Narasimhan to make Sandoz’s manufacturing and other operations independent of Novartis is nearly complete. But there are still some benefits from the combination....
...The Trump administration has committed to spend $1.95bn on 100m doses of a potential Covid-19 vaccine being developed by Germany’s BioNTech and US pharma giant Pfizer, which will be distributed free of charge...
...It could even top $100bn in 2022, a record for the pharma industry, some analysts suggest. This is more than a flash in the pan....
...The question gave the US pharma group a sense of urgency in the development of a coronavirus vaccine. Speed was crucial, so Pfizer had to change how it worked....
...Pfizer and its partner BioNTech plan to fill and finish vaccines at a manufacturing hub in South Africa from next year....
...Bourla said the vaccines had been created by “two miracles”: the original development and the scale-up of manufacturing....
...The company must show regulators that its manufacturing processes are consistent across all facilities....
...The US pharma group and German biotech, who together created the first mRNA-based Covid vaccine to win regulatory approval, said on Wednesday that they would work with the Biovac Institute in Cape Town....
...It is one of the few companies manufacturing devices that deliver a range of complex inhaled therapies. The cash offer compares with the 136-pence-a-share that Ventura had agreed with Carlyle....
...UDG’s valuation is boosted by its packaging manufacturing division Sharp, which represents a third of revenues and higher margins than Ashfield....
...“I’m not anti-Big Pharma . . . I think they have created a miracle, a scientific triumph,” he says....
...When Joe Biden toured Pfizer’s Covid-19 vaccine manufacturing plant in Kalamazoo, Michigan, earlier this year, his visit appeared to mark a thaw in relations between Washington and large pharmaceutical companies...
...When pharma companies were retrenching 10 years ago, he suspects early stage vaccine programmes were among those cut....
...“That could come back to haunt both pharma and the government if prices [for other drugs] continue to soar when Covid-19 is behind us.”...
...The company has previously said it splits profits with Pfizer 50-50 outside China, where it gets a 35-40 per cent share of gross profit in a deal with Fosun Pharma....
International Edition